Wnt/β-catenin in Ischemic Myocardium: Interactions and Signaling Pathways As a Therapeutic Target

Overview

Journal Heart Fail Rev

Date 2018 Dec 13

PMID 30539334

Citations 21

Authors

Habib Haybar

Elahe Khodadi

Saeid Shahrabi

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease (CVD) is still a factor of mortality in the whole world. Through canonical and noncanonical pathways and with different receptors, the Wnt/β-catenin signaling pathway plays an essential role in response to heart injuries. Wnt regulates the mobilization and proliferation of cells in endothelium and epicardium in an infarcted heart. Therefore, with its profibrotic effects as well as its antagonism with other proteins, Wnt/β-catenin signaling pathway leads to beneficial effects on fibrosis and cardiac remodeling in myocardium. In addition, Wnt increases the proliferation and differentiation of cardiac progenitors in an ischemic heart. Complex interactions and dual activity of Wnt, the changes in its expression, and mutations that can change its activity during heart development have an adverse effect on cardiac myocardium after injury. However, targeting the Wnt in myocardium with cellular and molecular pathways can be suggested to improve and repair ischemic heart. Given these challenges, in this review article, we deal with the role of Wnt/β-catenin signaling pathway as well as its interactions with other cells and molecules in an ischemic myocardium.

Citing Articles

Research progress of exosomes from different sources in myocardial ischemia.

Yan H, Ding H, Xie R, Liu Z, Yang X, Xie L Front Cardiovasc Med. 2024; 11:1436764.

PMID: 39350967 PMC: 11440518. DOI: 10.3389/fcvm.2024.1436764.

Muscle Psn gene combined with exercise contribute to healthy aging of skeletal muscle and lifespan by adaptively regulating Sirt1/PGC-1α and arm pathway.

Gao Y, Wen D, Du Z, Wang J, Wang S PLoS One. 2024; 19(5):e0300787.

PMID: 38753634 PMC: 11098322. DOI: 10.1371/journal.pone.0300787.

Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.

Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J Signal Transduct Target Ther. 2024; 9(1):12.

PMID: 38185705 PMC: 10772178. DOI: 10.1038/s41392-023-01688-x.

Stem cell antigen-1cell-derived fibroblasts are crucial for cardiac fibrosis during heart failure.

Tao T, Du L, Teng P, Guo Y, Wang X, Hu Y Cell Mol Life Sci. 2023; 80(10):300.

PMID: 37740736 PMC: 11073062. DOI: 10.1007/s00018-023-04957-8.

Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis.

Wang L, Du A, Lu Y, Zhao Y, Qiu M, Su Z J Am Heart Assoc. 2023; 12(10):e028866.

PMID: 37158154 PMC: 10227313. DOI: 10.1161/JAHA.122.028866.

References

Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, Bu L . The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell. 2008; 1(2):165-79. DOI: 10.1016/j.stem.2007.05.018. View

Lindsley R, Gill J, Murphy T, Langer E, Cai M, Mashayekhi M . Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell. 2008; 3(1):55-68. PMC: 2497439. DOI: 10.1016/j.stem.2008.04.004. View

Ezan J, Leroux L, Barandon L, Dufourcq P, Jaspard B, Moreau C . FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. Cardiovasc Res. 2004; 63(4):731-8. DOI: 10.1016/j.cardiores.2004.05.006. View

Deb A . Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury. Cardiovasc Res. 2014; 102(2):214-23. PMC: 3989450. DOI: 10.1093/cvr/cvu054. View

Zhu W, Shiojima I, Ito Y, Li Z, Ikeda H, Yoshida M . IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature. 2008; 454(7202):345-9. DOI: 10.1038/nature07027. View

Ferreira Tojais N, Peghaire C, Franzl N, Larrieu-Lahargue F, Jaspard B, Reynaud A . Frizzled7 controls vascular permeability through the Wnt-canonical pathway and cross-talk with endothelial cell junction complexes. Cardiovasc Res. 2014; 103(2):291-303. DOI: 10.1093/cvr/cvu133. View

Banerjee I, Fuseler J, Price R, Borg T, Baudino T . Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol. 2007; 293(3):H1883-91. DOI: 10.1152/ajpheart.00514.2007. View

Lorenzon A, Calore M, Poloni G, De Windt L, Braghetta P, Rampazzo A . Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy. Oncotarget. 2017; 8(36):60640-60655. PMC: 5601168. DOI: 10.18632/oncotarget.17457. View

Ye B, Ge Y, Perens G, Hong L, Xu H, Fishbein M . Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction. Cardiovasc Pathol. 2012; 22(1):54-7. PMC: 3427707. DOI: 10.1016/j.carpath.2012.03.004. View

10.

Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, Hassan A . Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A. 2003; 100(6):3299-304. PMC: 152286. DOI: 10.1073/pnas.0434590100. View

11.

Frangogiannis N . The immune system and cardiac repair. Pharmacol Res. 2008; 58(2):88-111. PMC: 2642482. DOI: 10.1016/j.phrs.2008.06.007. View

12.

Bergmann M . WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res. 2010; 107(10):1198-208. DOI: 10.1161/CIRCRESAHA.110.223768. View

13.

Bowley E, OGorman D, Gan B . Beta-catenin signaling in fibroproliferative disease. J Surg Res. 2006; 138(1):141-50. DOI: 10.1016/j.jss.2006.07.026. View

14.

Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, Rodgers L . Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J. 2011; 31(2):429-42. PMC: 3261567. DOI: 10.1038/emboj.2011.418. View

15.

Haybar H, Shahrabi S, Zayeri Z, Pezeshki S . Strategies to increase cardioprotection through cardioprotective chemokines in chemotherapy-induced cardiotoxicity. Int J Cardiol. 2018; 269:276-282. DOI: 10.1016/j.ijcard.2018.07.087. View

16.

Bastakoty D, Saraswati S, Joshi P, Atkinson J, Feoktistov I, Liu J . Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct. Cell Stem Cells Regen Med. 2017; 2(2). PMC: 5193163. DOI: 10.16966/2472-6990.111. View

17.

Haybar H, Khodadi E, Zibara K, Saki N . Platelet Activation Polymorphisms in Ischemia. Cardiovasc Hematol Disord Drug Targets. 2018; 18(2):153-161. DOI: 10.2174/1871529X18666180326121239. View

18.

Daskalopoulos E, Hermans K, Janssen B, Blankesteijn W . Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox?. Trends Cardiovasc Med. 2012; 23(4):121-7. DOI: 10.1016/j.tcm.2012.09.010. View

19.

Naito A, Shiojima I, Akazawa H, Hidaka K, Morisaki T, Kikuchi A . Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A. 2006; 103(52):19812-7. PMC: 1750922. DOI: 10.1073/pnas.0605768103. View

20.

Kobayashi K, Luo M, Zhang Y, Wilkes D, Ge G, Grieskamp T . Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol. 2008; 11(1):46-55. PMC: 2722759. DOI: 10.1038/ncb1811. View